Hopp til innhold

2021

Showing  0  hits

Sort by:
|
  1. Norwegian Institute of Public Health's recommendation  about AstraZeneca vaccine

    The Norwegian Institute of Public Health has recommended stopping further use of the AstraZeneca vaccine (Vaxzevria) in the Coronavirus Immunisation Programme in Norway.

    Published

  2. Pupils who reach puberty early do better at school

    Whether you reach puberty earlier or later can affect the grades you get at secondary school, according to a new study.

    Published

  3. Heavy metals and essential minerals during pregnancy and associations with ADHD and autism in children

    Levels of the heavy metals cadmium, lead, and arsenic and the essential mineral manganese during pregnancy, were associated with increased risk of ADHD and/or autism in the child.

    Published

  4. Extended pause for AstraZeneca vaccine

    The Norwegian Institute of Public Health has decided to extend the pause in the use of the AstraZeneca vaccine because further investigations are necessary.

    Published

  5. See signs of protection against COVID-19 among those vaccinated

    During the last five weeks, a sharp increase in transmission has been seen among most age groups in Norway, but not among the oldest who have the highest vaccination coverage.

    Published

  6. UK virus variant associated with higher risk of hospital admission

    The UK variant of the coronavirus is associated with a higher risk of being admitted to hospital, even among young adults, according to a new study from the Norwegian Institute of Public Health.

    Published

  7. AstraZeneca vaccine still on hold in Norway

    The Norwegian Institute of Public Health (NIPH) will keep use of the AstraZeneca vaccine on hold in Norway and will continue a thorough review of the situation. An update will be provided at the end of week 12.

    Published

  8. AstraZeneca vaccine: When to consult a doctor

    An overview of common side effects after AstraZeneca vaccination, and what people should be alert for, is released by the Norwegian Medicines Agency and the Norwegian Institute of Public Health.

    Published

  9. Norwegian Medicines Agency notified of blood clots and bleeding in younger people after vaccination with AstraZeneca vaccine

    The Norwegian Medicine Agency is asking people who had the AstraZeneca vaccine in the last 14 days and who feel increasingly unwell to be alert.

    Published

  10. Norwegian Medicines Agency investigating notification about death

    The Norwegian Medicines Agency and the Norwegian Institute of Public Health (NIPH) have received a report of a death following vaccination with the AstraZeneca vaccine.

    Published

  11. Vaccination with AstraZeneca vaccine against COVID-19 put on hold

    Following a report in Denmark of a death from a blood clot after receiving the AstraZeneca vaccine, Norway has chosen to suspend vaccination with the AstraZeneca vaccine.

    Published

  12. Changes in the vaccine strategy

    The Norwegian Institute of Public Health will allocate more vaccine doses to areas at particular risk for infection and introduce a new distribution key for vaccines.

    Published

  13. AstraZeneca vaccine recommended for all over 18 years of age

    The Norwegian Institute of Public Health (NIPH) now recommends giving the coronavirus vaccine from AstraZeneca to people over the age of 18.

    Published

  14. Assisted reproduction affects children’s growth, but only in the first years

    Children born after assisted reproduction are smaller at birth, but grow faster during the first years of life, compared to naturally conceived children.

    Published

  15. The Smittestopp app now works across national borders

    Today, the Norwegian Smittestopp app was linked to other infection tracking apps in the EU and EEA.

    Published

  16. International interest about deaths following coronavirus vaccination

    A large proportion of people offered coronavirus vaccination first were the elderly, often with severe underlying diseases. Deaths in connection with vaccination have attracted international interest.

    Published

  17. Temporary reduction in vaccine supplies to Europe from Pfizer

    Pfizer has announced reduced vaccine deliveries starting next week and for some time ahead. The NIPH has an emergency stockpile and can deliver as planned to municipalities and health services.

    Published